-
Mashup Score: 1
After left atrial appendage occlusion with a next-generation device, patients with atrial fibrillation had similar outcomes at 45 days regardless of medication regimen, researchers reported at TVT: The Structural Heart Summit.From a database of patients who underwent left atrial appendage (LAA) occlusion with the next-generation device (Watchman FLX, Boston Scientific) and were included in the
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Socioeconomically disadvantaged patients underrepresented in structural heart trials - 2 year(s) ago
Among hospitals performing transcatheter mitral and tricuspid valve therapies, those involved in clinical trials had fewer socioeconomically disadvantaged patients than those not involved, researchers reported.There were no significant differences by race and ethnicity between patients from trial hospitals and those from non-trial hospitals.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: “These data would suggest that broader inclusion of potential clinical trial sites may improve access to clinical trials among socioeconomically disadvantaged patients," @ashwin_nathan #TVT2022 @PennMedNews #CardioTwitter https://t.co/2V5XqCSzwf
-
-
Mashup Score: 0Socioeconomically disadvantaged patients underrepresented in structural heart trials - 2 year(s) ago
Among hospitals performing transcatheter mitral and tricuspid valve therapies, those involved in clinical trials had fewer socioeconomically disadvantaged patients than those not involved, researchers reported.There were no significant differences by race and ethnicity between patients from trial hospitals and those from non-trial hospitals.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: “These data would suggest that broader inclusion of potential clinical trial sites may improve access to clinical trials among socioeconomically disadvantaged patients," @ashwin_nathan #TVT2022 @PennMedNews #CardioTwitter https://t.co/2V5XqCSzwf
-
-
Mashup Score: 2Socioeconomically disadvantaged patients underrepresented in structural heart trials - 2 year(s) ago
Among hospitals performing transcatheter mitral and tricuspid valve therapies, those involved in clinical trials had fewer socioeconomically disadvantaged patients than those not involved, researchers reported.There were no significant differences by race and ethnicity between patients from trial hospitals and those from non-trial hospitals.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Among hospitals performing transcatheter mitral and tricuspid valve therapies, those involved in clinical trials had fewer socioeconomically disadvantaged patients than those not involved @ashwin_nathan #TVT2022 @PennMedNews #CardioTwitter https://t.co/2V5XqCSzwf
-
-
Mashup Score: 0TAVR Devices Keep Changing -- Is This Really Helping Patients? - 2 year(s) ago
Clinical outcomes are headed in the right direction, but better research is needed
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Tweaks made to Medtronic's CoreValve transcatheter heart valve line in the last few years have tracked with some improved outcomes after transcatheter aortic valve replacement, reported @AndreaScotti21 at #TVT2022. By @nicolejlou. #cardiotwitter #TAVR https://t.co/o87fhoKbox
-
-
Mashup Score: 0Promising First Dips Into a Bigger Pool of MitraClip Candidates - 2 year(s) ago
Real-world outcomes in people with secondary MR who don’t fit COAPT criteria
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Emerging real-world data supported benefits of MitraClip therapy in patients with secondary mitral regurgitation who didn't fit the COAPT profile, reported @GilbertTangMD at #TVT2022. By @nicolejlou. #cardiotwitter https://t.co/s1ylu5MNgm
-
-
Mashup Score: 2
Investigators caution this is an apples-to-oranges comparison, given the complexity of surgical removal of a failed THV.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
Thank you @TCTMD @michaelTCTMD for the great article #TVT2022 @crfheart on our EXPLANTORREDO #TAVR registry on TAVR failure at 29 sites. Interesting findings! Great job DrSyedZaid @HMethodistCV presenting & thank you all collaborators. @SachinGoelMD https://t.co/zE5xK2WnRn
-
-
Mashup Score: 5Social Media Ambassadors | TVT 2022 - 2 year(s) ago
Sign Up for Our NewsletterGet the latest news and information from CRF.By submitting your email address, you agree to CRF’s Privacy Policy & Terms and Conditions.1700 Broadway, 9th FloorNew York, NY 10019646.434.4500info@crf.org© 2022, Cardiovascular Research Foundation. All rights reserved.Privacy PolicyTerms and Conditions of Use
Source: tvt2022.crfconnect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A special thanks goes out to our social media ambassadors! Thank you for making #TVT2022 an incredible learning experience for all. https://t.co/OoXabyUgdv #CardioTwitter #CardioEd @Almanfi_Cardio @PhilippLurz @purviparwani @Pooh_Velagapudi https://t.co/q7vTDhyH69
-
-
Mashup Score: 0
Registry results imply that HF patients who wouldn’t have been eligible for COAPT—even the very sick—did well with TEER.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
Thank you @TCTMD @michaelTCTMD for the great interview and article on #MitraClip EXPAND SMR #COAPT vs non-COAPT like study #LBCS #TVT2022 @crfheart @AbbottCardio @MountSinaiHeart @MountSinaiNYC https://t.co/CA7xRLXCq7
-
-
Mashup Score: 5TVT 2022 - 2 year(s) ago
Thank you for making TVT 2022 a huge success! About TVT 2022Now in its 15th year, TVT: The Structural Heart Summit has grown to reflect the changing landscape of treating structural heart disease via transcatheter aortic valve replacement and transcatheter mitral and tricuspid therapies. Known for connecting the brightest minds in the structural heart arena, TVT 2022 features three days of…
Source: tvt2022.crfconnect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Don't miss a live case from @OHSUNews starting at 3:30 PM CT! #heartfailure #TVT2022 https://t.co/mPZIRlNjhg #CardioEd TEER in Functional MR – HF Perspectives @anita_asgar @mszerlip @IsidaByku @HamidNadira @NishthaSodhi @PDXHeartValveMD @HarshGMD @heartsonthehill https://t.co/spg6Zb6hT5
-
After LAA occlusion with a next-generation device, patients with #AFib had similar outcomes at 45 days regardless of medication regimen, researchers reported at #TVT2022 @MCoylewright @erlangerhealth #CardioTwitter https://t.co/NKYXBcUrVT